OliX PharmaceuticalsI (Korea) Probability of Future Stock Price Finishing Under 18,647

226950 Stock   16,990  500.00  3.03%   
OliX PharmaceuticalsI's future price is the expected price of OliX PharmaceuticalsI instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of OliX PharmaceuticalsInc performance during a given time horizon utilizing its historical volatility. Check out OliX PharmaceuticalsI Backtesting, OliX PharmaceuticalsI Valuation, OliX PharmaceuticalsI Correlation, OliX PharmaceuticalsI Hype Analysis, OliX PharmaceuticalsI Volatility, OliX PharmaceuticalsI History as well as OliX PharmaceuticalsI Performance.
  
Please specify OliX PharmaceuticalsI's target price for which you would like OliX PharmaceuticalsI odds to be computed.

OliX PharmaceuticalsI Target Price Odds to finish below 18,647

The tendency of OliX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move below current price in 90 days
 16,990 90 days 16,990 
about 8.69
Based on a normal probability distribution, the odds of OliX PharmaceuticalsI to move below current price in 90 days from now is about 8.69 (This OliX PharmaceuticalsInc probability density function shows the probability of OliX Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.39 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, OliX PharmaceuticalsI will likely underperform. Additionally OliX PharmaceuticalsInc has an alpha of 0.1433, implying that it can generate a 0.14 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   OliX PharmaceuticalsI Price Density   
       Price  

Predictive Modules for OliX PharmaceuticalsI

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as OliX PharmaceuticalsInc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
16,48216,49016,498
Details
Intrinsic
Valuation
LowRealHigh
15,82315,83018,139
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as OliX PharmaceuticalsI. Your research has to be compared to or analyzed against OliX PharmaceuticalsI's peers to derive any actionable benefits. When done correctly, OliX PharmaceuticalsI's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in OliX PharmaceuticalsInc.

OliX PharmaceuticalsI Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. OliX PharmaceuticalsI is not an exception. The market had few large corrections towards the OliX PharmaceuticalsI's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold OliX PharmaceuticalsInc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of OliX PharmaceuticalsI within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.14
β
Beta against Dow Jones1.39
σ
Overall volatility
3,885
Ir
Information ratio 0.02

OliX PharmaceuticalsI Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OliX PharmaceuticalsI for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OliX PharmaceuticalsInc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
OliX PharmaceuticalsI generated a negative expected return over the last 90 days
OliX PharmaceuticalsI has high historical volatility and very poor performance
The company reported the revenue of 3.67 B. Net Loss for the year was (30.28 B) with profit before overhead, payroll, taxes, and interest of 2.42 B.
OliX PharmaceuticalsInc has accumulated about 34.34 B in cash with (19.05 B) of positive cash flow from operations.
Roughly 29.0% of the company shares are owned by insiders or employees

OliX PharmaceuticalsI Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OliX Stock often depends not only on the future outlook of the current and potential OliX PharmaceuticalsI's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OliX PharmaceuticalsI's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding13.7 M
Cash And Short Term Investments49.8 B
Shares Float9.2 M

OliX PharmaceuticalsI Technical Analysis

OliX PharmaceuticalsI's future price can be derived by breaking down and analyzing its technical indicators over time. OliX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of OliX PharmaceuticalsInc. In general, you should focus on analyzing OliX Stock price patterns and their correlations with different microeconomic environments and drivers.

OliX PharmaceuticalsI Predictive Forecast Models

OliX PharmaceuticalsI's time-series forecasting models is one of many OliX PharmaceuticalsI's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary OliX PharmaceuticalsI's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about OliX PharmaceuticalsInc

Checking the ongoing alerts about OliX PharmaceuticalsI for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for OliX PharmaceuticalsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
OliX PharmaceuticalsI generated a negative expected return over the last 90 days
OliX PharmaceuticalsI has high historical volatility and very poor performance
The company reported the revenue of 3.67 B. Net Loss for the year was (30.28 B) with profit before overhead, payroll, taxes, and interest of 2.42 B.
OliX PharmaceuticalsInc has accumulated about 34.34 B in cash with (19.05 B) of positive cash flow from operations.
Roughly 29.0% of the company shares are owned by insiders or employees

Other Information on Investing in OliX Stock

OliX PharmaceuticalsI financial ratios help investors to determine whether OliX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OliX with respect to the benefits of owning OliX PharmaceuticalsI security.